These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17229577)

  • 21. Dextromethorphan is protective against sensitized N-methyl-D-aspartate receptor-mediated excitotoxic brain damage in the developing mouse brain.
    Keller M; Griesmaier E; Auer M; Schlager G; Urbanek M; Simbruner G; Gressens P; Sárközy G
    Eur J Neurosci; 2008 Feb; 27(4):874-83. PubMed ID: 18279363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans.
    Schley M; Ständer S; Kerner J; Vajkoczy P; Schüpfer G; Dusch M; Schmelz M; Konrad C
    Brain Res Bull; 2009 Jun; 79(5):333-7. PubMed ID: 19480992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective agents: cannabinoids.
    Sánchez AJ; García-Merino A
    Clin Immunol; 2012 Jan; 142(1):57-67. PubMed ID: 21420365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.
    Benito C; Romero JP; Tolón RM; Clemente D; Docagne F; Hillard CJ; Guaza C; Romero J
    J Neurosci; 2007 Feb; 27(9):2396-402. PubMed ID: 17329437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoids, multiple sclerosis and neuroprotection.
    de Lago E; Gómez-Ruiz M; Moreno-Martet M; Fernández-Ruiz J
    Expert Rev Clin Pharmacol; 2009 Nov; 2(6):645-60. PubMed ID: 22112258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.
    Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J
    Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart.
    Hajrasouliha AR; Tavakoli S; Ghasemi M; Jabehdar-Maralani P; Sadeghipour H; Ebrahimi F; Dehpour AR
    Eur J Pharmacol; 2008 Jan; 579(1-3):246-52. PubMed ID: 17950273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance.
    Gómez M; Hernández ML; Pazos MR; Tolón RM; Romero J; Fernández-Ruiz J
    Neuroscience; 2008 May; 153(3):687-99. PubMed ID: 18400407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice.
    Avraham Y; Zolotarev O; Grigoriadis NC; Poutahidis T; Magen I; Vorobiav L; Zimmer A; Ilan Y; Mechoulam R; Berry EM
    Am J Gastroenterol; 2008 Dec; 103(12):3047-56. PubMed ID: 19086956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The endocannabinoid system as a novel target for the treatment of liver fibrosis].
    Teixeira-Clerc F; Julien B; Grenard P; Tran Van Nhieu J; Deveaux V; Hezode C; Mallat A; Lotersztajn S
    Pathol Biol (Paris); 2008 Feb; 56(1):36-8. PubMed ID: 17412522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision.
    Romero-Sandoval A; Eisenach JC
    Anesthesiology; 2007 Apr; 106(4):787-94. PubMed ID: 17413917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoids.
    López-Rodríguez ML
    Mini Rev Med Chem; 2005 Jul; 5(7):607. PubMed ID: 16026306
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of cannabinoids in chronic liver diseases.
    Parfieniuk A; Flisiak R
    World J Gastroenterol; 2008 Oct; 14(40):6109-14. PubMed ID: 18985799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis.
    Marquart S; Zerr P; Akhmetshina A; Palumbo K; Reich N; Tomcik M; Horn A; Dees C; Engel M; Zwerina J; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Nov; 62(11):3467-76. PubMed ID: 20617520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cannabinoids in multiple sclerosis -- therapeutically reasonable?].
    Trebst C; Stangel M
    Fortschr Neurol Psychiatr; 2005 Aug; 73(8):463-9. PubMed ID: 16052440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxaza adamantyl cannabinoids. A new class of cannabinoid receptor probes.
    Le Goanvic D; Tius MA
    J Org Chem; 2006 Sep; 71(20):7800-4. PubMed ID: 16995689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids to treat spinal cord injury.
    Arevalo-Martin A; Molina-Holgado E; Garcia-Ovejero D
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():190-9. PubMed ID: 25805333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential cannabinoid receptor expression during reactive gliosis: a possible implication for a nonpsychotropic neuroprotection.
    De Filippis D; Steardo A; D'Amico A; Scuderi C; Cipriano M; Esposito G; Iuvone T
    ScientificWorldJournal; 2009 Mar; 9():229-35. PubMed ID: 19347234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The endocannabinoid system in amyotrophic lateral sclerosis.
    Bilsland LG; Greensmith L
    Curr Pharm Des; 2008; 14(23):2306-16. PubMed ID: 18781981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoids and neuroprotection in motor-related disorders.
    de Lago E; Fernández-Ruiz J
    CNS Neurol Disord Drug Targets; 2007 Dec; 6(6):377-87. PubMed ID: 18220777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.